Pro Medicus Ltd
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of PME-AX would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2000) — listing | $5,679,536 145.2× | $8,165,719 145.2× |
| Year 6 (2005) | $4,162,692 128.2× | $6,035,661 128.7× |
| Year 11 (2010) | $2,909,414 116.9× | $4,228,422 117.6× |
| Year 16 (2015) | $248,680 14.4× | $358,101 14.3× |
| Year 21 (2020) | $22,075 2.3× | $31,769 2.3× |
| Year 26 (2025) | $1,339 0.6× | $1,930 0.6× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with PME
For illustration only — not investment advice. Past performance is not indicative of future results.